Geode Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.1M | Buy |
6,074,458
+1,043,718
| +21% | +$3.8M | ﹤0.01% | 1906 |
|
|
2025
Q1 | $9.66M | Buy |
5,030,740
+235,645
| +5% | +$453K | ﹤0.01% | 2315 |
|
|
2024
Q4 | $9.11M | Buy |
4,795,095
+40,631
| +0.9% | +$77.2K | ﹤0.01% | 2436 |
|
|
2024
Q3 | $6.28M | Buy |
4,754,464
+218,172
| +5% | +$288K | ﹤0.01% | 2644 |
|
|
2024
Q2 | $4.63M | Buy |
4,536,292
+2,717,345
| +149% | +$2.77M | ﹤0.01% | 2774 |
|
|
2024
Q1 | $3.33M | Buy |
1,818,947
+17,257
| +1% | +$31.6K | ﹤0.01% | 2908 |
|
|
2023
Q4 | $2.23M | Buy |
1,801,690
+77,416
| +4% | +$96K | ﹤0.01% | 3059 |
|
|
2023
Q3 | $1.97M | Sell |
1,724,274
-48,703
| -3% | -$55.5K | ﹤0.01% | 3081 |
|
|
2023
Q2 | $1.62M | Buy |
1,772,977
+90,479
| +5% | +$82.8K | ﹤0.01% | 3178 |
|
|
2023
Q1 | $943K | Hold |
1,682,498
| – | – | ﹤0.01% | 3377 |
|
|
2022
Q4 | $970K | Buy |
1,682,498
+60,673
| +4% | +$35K | ﹤0.01% | 3352 |
|
|
2022
Q3 | $512K | Buy |
1,621,825
+4,432
| +0.3% | +$1.4K | ﹤0.01% | 3712 |
|
|
2022
Q2 | $571K | Sell |
1,617,393
-1,535,365
| -49% | -$542K | ﹤0.01% | 3693 |
|
|
2022
Q1 | $2.26M | Sell |
3,152,758
-55,231
| -2% | -$39.6K | ﹤0.01% | 3203 |
|
|
2021
Q4 | $7.25M | Sell |
3,207,989
-21,954
| -0.7% | -$49.6K | ﹤0.01% | 2663 |
|
|
2021
Q3 | $9.3M | Buy |
3,229,943
+307,291
| +11% | +$885K | ﹤0.01% | 2498 |
|
|
2021
Q2 | $11.1M | Buy |
2,922,652
+323,845
| +12% | +$1.23M | ﹤0.01% | 2389 |
|
|
2021
Q1 | $8.8M | Buy |
2,598,807
+374,236
| +17% | +$1.27M | ﹤0.01% | 2442 |
|
|
2020
Q4 | $6.23M | Buy |
2,224,571
+67,953
| +3% | +$190K | ﹤0.01% | 2481 |
|
|
2020
Q3 | $5.41M | Buy |
2,156,618
+54,909
| +3% | +$138K | ﹤0.01% | 2344 |
|
|
2020
Q2 | $28.5M | Buy |
2,101,709
+276,943
| +15% | +$3.76M | 0.01% | 1240 |
|
|
2020
Q1 | $13.8M | Buy |
1,824,766
+166,938
| +10% | +$1.27M | ﹤0.01% | 1538 |
|
|
2019
Q4 | $10.5M | Buy |
1,657,828
+79,006
| +5% | +$499K | ﹤0.01% | 1983 |
|
|
2019
Q3 | $6.19M | Buy |
1,578,822
+79,729
| +5% | +$312K | ﹤0.01% | 2254 |
|
|
2019
Q2 | $7.26M | Buy |
1,499,093
+234,774
| +19% | +$1.14M | ﹤0.01% | 2153 |
|
|
2019
Q1 | $10.4M | Buy |
1,264,319
+252,775
| +25% | +$2.07M | ﹤0.01% | 1873 |
|
|
2018
Q4 | $5.59M | Buy |
1,011,544
+373,594
| +59% | +$2.07M | ﹤0.01% | 2152 |
|
|
2018
Q3 | $5.63M | Buy |
637,950
+52,556
| +9% | +$464K | ﹤0.01% | 2278 |
|
|
2018
Q2 | $5.84M | Buy |
585,394
+35,159
| +6% | +$351K | ﹤0.01% | 2233 |
|
|
2018
Q1 | $5.24M | Buy |
550,235
+48,972
| +10% | +$467K | ﹤0.01% | 2207 |
|
|
2017
Q4 | $7.45M | Sell |
501,263
-54,654
| -10% | -$813K | ﹤0.01% | 1953 |
|
|
2017
Q3 | $10.9M | Buy |
555,917
+227,736
| +69% | +$4.48M | ﹤0.01% | 1656 |
|
|
2017
Q2 | $4.72M | Sell |
328,181
-1,915
| -0.6% | -$27.5K | ﹤0.01% | 2182 |
|
|
2017
Q1 | $3.04M | Buy |
330,096
+14,959
| +5% | +$138K | ﹤0.01% | 2413 |
|
|
2016
Q4 | $3.28M | Buy |
315,137
+6,732
| +2% | +$70.1K | ﹤0.01% | 2329 |
|
|
2016
Q3 | $2.79M | Buy |
308,405
+80,036
| +35% | +$724K | ﹤0.01% | 2347 |
|
|
2016
Q2 | $1.71M | Buy |
228,369
+7,790
| +4% | +$58.3K | ﹤0.01% | 2576 |
|
|
2016
Q1 | $1.99K | Buy |
220,579
+73,871
| +50% | +$665 | ﹤0.01% | 2467 |
|
|
2015
Q4 | $1.9M | Buy |
146,708
+19,017
| +15% | +$246K | ﹤0.01% | 2521 |
|
|
2015
Q3 | $1.23M | Buy |
127,691
+5,932
| +5% | +$57.3K | ﹤0.01% | 2754 |
|
|
2015
Q2 | $1.25M | Buy |
121,759
+78,821
| +184% | +$810K | ﹤0.01% | 2786 |
|
|
2015
Q1 | $477K | Buy |
42,938
+2,640
| +7% | +$29.3K | ﹤0.01% | 3211 |
|
|
2014
Q4 | $469K | Buy |
40,298
+4,279
| +12% | +$49.8K | ﹤0.01% | 3223 |
|
|
2014
Q3 | $797K | Buy |
36,019
+6,108
| +20% | +$135K | ﹤0.01% | 2923 |
|
|
2014
Q2 | $831K | Buy |
+29,911
| New | +$831K | ﹤0.01% | 2900 |
|